Microneedle Drug Delivery Systems Market - Global Industry Analysis

Microneedle Drug Delivery Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Pharmaceutical Report Format : PDF Report Code: ZMR-5784 Status : Upcoming

Description

Global Microneedle Drug Delivery Systems Market: Overview

Microneedle drug delivery system is a novel drug delivery system method in which the drug is delivered in the systemic circulation with the use of needles. It is a great way to deliver drugs safely, non-invasively, and painlessly in the skin. Microneedle may be an array or single and consist of hundreds or thousands of micro projections, with a diameter of hundreds of microns and length up to 2mm that are attached to the base support. Small molecule to macromolecular drugs and vaccines can be easily and precisely delivered by microneedle drug delivery systems.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global Microneedle Drug Delivery Systems Market: Growth Factors

The global microneedle drug delivery systems market is growing at a substantial rate. The factors contributing to the growth of the market include the growing need for advanced drug delivery systems for novel drugs, the increasing need for efficient drug transfer to targeted portions, and advancement in medical technologies. Furthermore, the growing need for safe and painless drug delivery systems, especially in children is driving the growth of the market. Microneedle does not only help to inject the drug with the proper concentration in the skin but also delivers it safely without pain. Moreover, microneedle drug delivery systems offer a smart approach to deliver drugs by increasing the potential for transdermal drug delivery systems. All these and many other factors are expected to boost the growth of the global microneedle drug delivery systems market. On the other side, lack of awareness about microneedle drug delivery systems and continuing preference for conventional low-cost drug delivery systems may hinder the growth of the market over the forecast period. However, advancement in medical technology, growing adoption of newer medical technologies due to heavy investments in the healthcare sector by developing countries is expected to offer better opportunities to the global microneedle drug delivery systems market growth during the forecast period.

COVID 19 pandemic conditions have severely affected the growth of the global microneedle drug delivery systems market. COVID 19 pandemic situations do not only shift the focus of healthcare professional to control the infection but also postponed other medical procedures which were scheduled before the pandemic. This has badly affected the demand for microneedle drug delivery systems in medical procedures. Also, strict lockdowns imposed by several governments and restrictions on personnel movement resulted in a halt in the manufacturing of microneedle drug delivery systems. Major players are struggling to fulfill the demand for products globally. However, the market is expected to jump back to its pace by the mid of 2021.

Global Microneedle Drug Delivery Systems Market: Segmentation

The global microneedle drug delivery systems market is categorized into the application, technology, source type, end-user, and region. Based on the application, the global microneedle drug delivery systems market is bifurcated into dermatology, cardiovascular, neurology, oncology, and others. Based on the technology, the global market is classified into solid, porous, hollow, and others. The source types segment is divided into polysaccharides, metals, polymers, silicon, and others. Based on the end-user, the market is split into hospitals, diagnostic laboratories, ambulatory surgical centers, and life science & research laboratories.

Global Microneedle Drug Delivery Systems Market: Regional Analysis

Among the regions, North America is predicted to hold the largest share in the global microneedle drug delivery systems market in terms of revenue during the forecast period. Factors such as the presence of well-established healthcare infrastructure with state-of-the-art facilities, awareness related to advantages of the microneedle drug delivery systems for the treatment of diseases among the patients, and proper guidelines for early diagnosis & treatment are augmenting the growth of the market in this region. Europe on the other hand holds second-most position in the market and is estimated to contribute to a significant share in the market. Major key players investing hugely in the development of drug delivery systems and growing medical technology are the factors that are contributing to the growth of the market in this region. The market in Asia Pacific is expected to grow at a faster rate due to the rise in healthcare expenditure, growing economies, and healthcare infrastructure.

Global Microneedle Drug Delivery Systems Market: Competitive Players

Some of the prominent players operating in the global microneedle drug delivery systems market are Stemedica Cell Technologies, Inc., Phillips Plastic Corporation, Innoture Medical Technology Limited, Micropoint Technologies Pte Ltd, Zosano Pharma Corporation, nanoBioSciences LLC, Vetter Pharma International GmbH, 3M, MyLife Technologies, and Corium International, Inc.

Global Microneedle Drug Delivery Systems Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global microneedle drug delivery systems market is growing at a substantial rate. The factors contributing to the growth of the market include the growing need for advanced drug delivery systems for novel drugs, the increasing need for efficient drug transfer to targeted portions, and advancement in medical technologies. Furthermore, advancement in medical technology, growing adoption of newer medical technologies due to heavy investments in the healthcare sector by developing countries is expected to offer better opportunities to the global microneedle drug delivery systems market growth during the forecast period.

Some of the prominent players operating in the global microneedle drug delivery systems market are Stemedica Cell Technologies, Inc., Phillips Plastic Corporation, Innoture Medical Technology Limited, Micropoint Technologies Pte Ltd, Zosano Pharma Corporation, nanoBioSciences LLC, Vetter Pharma International GmbH, 3M, MyLife Technologies, and Corium International, Inc.

Among the regions, North America is predicted to hold the largest share in the global microneedle drug delivery systems market in terms of revenue during the forecast period. Factors such as the presence of well-established healthcare infrastructure with state-of-the-art facilities, awareness related to advantages of the microneedle drug delivery systems for the treatment of diseases among the patients, and proper guidelines for early diagnosis & treatment are augmenting the growth of the market in this region.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed